Azitra is trading 32.48% down at $0.08, with no clear company-specific announcement explaining the October 13 decline. - The latest company news identified was an October 1 update allowing ATR-04 to proceed to Cohort 2 after a safety review. - The supplied sector context shows XBI down 2.01% during the session, with no clear sector-wide catalyst; this does not establish the cause of Azitra’s larger drop.